Study ties bisphosphonates to higher risk of abnormal heartbeat

10/9/2013 | MedPage Today (free registration)

A systematic review of 12 studies involving more than 190,000 patients showed bisphosphonate therapy was linked with a 27% higher risk of atrial fibrillation and 40% increased risk of serious atrial fibrillation. Bisphosphonate use, however, did not raise patients' risk of stroke or cardiovascular death. The findings appeared in the journal Chest.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX